David Hite is the Managing Partner at B37 Ventures, a San Francisco-based venture capital firm where he leverages over. See sector focus and contact routes.
David Hite is the Managing Partner at B37 Ventures, a San Francisco-based venture capital firm where he leverages over 30 years of business development experience, including two decades at Intel and a prior role as CEO of Alandra Medical. His firm targets early-stage technology startups in the United States, investing across Seed, Series A, and Series B+ rounds with a focus on sectors like Enterprise SaaS, Planetary Health, and Engineered Biology. B37 Ventures typically executes checks ranging from $100,000 to $3.0 million, operating primarily at pre-seed, seed, and Series A stages. While the firm has nine tracked investments, notable portfolio companies include Ansa, which received a $14.0 million Series A in April 2024, and Metaplane. Hite distinguishes himself through a global perspective, having established 15 startup teams in 11 countries and lived in eight, which informs his thesis on companies with global potential. He publicly emphasizes bridging disruptive startups with multinational corporations to accelerate innovation, describing himself as a strategist passionate about creating things that did not previously exist.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.
Investors like David Hite · Full investor directory · Investor access · Company funding database